GADO, FRANCESCA
 Distribuzione geografica
Continente #
AS - Asia 1.899
NA - Nord America 1.714
EU - Europa 1.587
SA - Sud America 267
AF - Africa 79
OC - Oceania 25
Totale 5.571
Nazione #
US - Stati Uniti d'America 1.599
IT - Italia 631
CN - Cina 611
SG - Singapore 602
DE - Germania 256
HK - Hong Kong 251
BR - Brasile 205
SE - Svezia 114
IN - India 103
RU - Federazione Russa 93
NL - Olanda 85
GB - Regno Unito 66
ID - Indonesia 63
VN - Vietnam 60
FR - Francia 59
ES - Italia 58
CA - Canada 57
MX - Messico 50
FI - Finlandia 47
IE - Irlanda 46
CI - Costa d'Avorio 33
JP - Giappone 30
TR - Turchia 27
PL - Polonia 25
IL - Israele 24
KR - Corea 23
TW - Taiwan 22
AR - Argentina 21
BD - Bangladesh 19
AU - Australia 17
AT - Austria 15
PT - Portogallo 15
IQ - Iraq 12
CH - Svizzera 11
EC - Ecuador 11
UA - Ucraina 11
CL - Cile 10
CO - Colombia 10
EG - Egitto 10
IR - Iran 9
RO - Romania 9
ZA - Sudafrica 9
NZ - Nuova Zelanda 8
PK - Pakistan 8
GR - Grecia 7
MA - Marocco 6
MY - Malesia 6
BE - Belgio 5
HU - Ungheria 5
BG - Bulgaria 4
CY - Cipro 4
DK - Danimarca 4
DZ - Algeria 4
LT - Lituania 4
LV - Lettonia 4
TH - Thailandia 4
CR - Costa Rica 3
KE - Kenya 3
NG - Nigeria 3
PE - Perù 3
PH - Filippine 3
TN - Tunisia 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
CU - Cuba 2
EE - Estonia 2
JO - Giordania 2
LU - Lussemburgo 2
MR - Mauritania 2
NO - Norvegia 2
NP - Nepal 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
HR - Croazia 1
KZ - Kazakistan 1
LC - Santa Lucia 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
PY - Paraguay 1
SC - Seychelles 1
SN - Senegal 1
SR - Suriname 1
ZW - Zimbabwe 1
Totale 5.571
Città #
Singapore 285
Dallas 229
Ashburn 227
Milan 225
Hong Kong 224
Hanover 160
Hefei 103
Los Angeles 100
Beijing 98
Chicago 80
Santa Clara 72
San Jose 63
Bengaluru 49
Dublin 47
New York 42
Princeton 42
Jakarta 40
Phoenix 39
Council Bluffs 34
Abidjan 33
Salt Lake City 31
Chandler 28
Buffalo 27
Helsinki 26
Ho Chi Minh City 26
São Paulo 25
London 24
Cambridge 22
Tokyo 22
Frankfurt am Main 21
Moscow 21
Munich 21
Pisa 21
Shanghai 21
Boardman 20
Guangzhou 20
Istanbul 19
Tampa 18
Rome 17
Nuremberg 15
Cangzhou 14
Montreal 14
Lappeenranta 13
Warsaw 13
Florence 12
Pittsburgh 12
Sydney 11
Toronto 11
Denver 10
Elk Grove Village 10
Mumbai 10
Santiago 10
Tel Aviv 10
The Dalles 10
Wilmington 10
Hyderabad 9
Brooklyn 8
Campinas 8
Chennai 8
Columbus 8
Monza 8
Naples 8
Orem 8
Revere 8
Rio de Janeiro 8
Santiago de Compostela 8
Silver Spring 8
Sterling 8
Taipei 8
Tianjin 8
Bat Yam 7
Calci 7
Detroit 7
Fairfield 7
Livorno 7
Nanjing 7
Naucalpan 7
Seattle 7
Seoul 7
Turku 7
Arcadia 6
Atlanta 6
Bologna 6
Brescia 6
Buenos Aires 6
Falkenstein 6
Fortaleza 6
Hanoi 6
Lucca 6
Miami 6
Padova 6
San Diego 6
Turin 6
Vicenza 6
Yongin-si 6
Amsterdam 5
Araripe 5
Attleboro 5
Auckland 5
Baghdad 5
Totale 3.113
Nome #
Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: Implications for drug discovery 504
Unraveling the parahormetic mechanism underlying the health-protecting effects of grapeseed procyanidins 422
Phenolic compounds in prevention and treatment of skin cancers: A review 315
Bergamot leaf extract treats cardiorenal metabolic syndrome and associated pathophysiological factors in rats fed with a high sugar fat diet 270
Achillea moschata Wulfen: From Ethnobotany to Phytochemistry, Morphology, and Biological Activity 257
Targeting Nrf2 and NF-κB Signaling Pathways in Cancer Prevention: The Role of Apple Phytochemicals 230
Design, synthesis, ADME and biological evaluation of benzylpiperidine and benzylpiperazine derivatives as novel reversible monoacylglycerol lipase (MAGL) inhibitors 208
Polyphenols from Thinned Young Apples: HPLC-HRMS Profile and Evaluation of Their Anti-Oxidant and Anti-Inflammatory Activities by Proteomic Studies 194
Liquid Chromatography–High-Resolution Mass Spectrometry (LC-HRMS) Profiling of Commercial Enocianina and Evaluation of Their Antioxidant and Anti-Inflammatory Activity 193
Chemical, Nutritional and Biological Evaluation of a Sustainable and Scalable Complex of Phytochemicals from Bergamot By-Products 183
Anti-inflammatory activity of a cb2 selective cannabinoid receptor agonist: Signaling and cytokines release in blood mononuclear cells 181
The Department’s green heart, from the Botanic Garden to ethnobotany 177
Design, synthesis and biological evaluation of novel orthosteric-allosteric ligands of the cannabinoid receptor type 2 (CB2R) 174
Development of potent dual PDK1/AurA kinase inhibitors for cancer therapy: Lead-optimization, structural insights, and ADME-Tox profile 145
New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2 142
CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulators 127
The Potential of Polyphenols in Modulating the Cellular Senescence Process: Implications and Mechanism of Action 118
Pre-ADMET studies of 5-(3′,4′-dihydroxyphenyl)-γ-valerolactone, the bioactive intestinal metabolite of proanthocyanidins 118
Synthesis and In Vitro Characterization of Selective Cannabinoid {CB}2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer Cells 117
Design, Synthesis, and Biological Activity of New {CB}2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands 111
The role of cannabinoids in bone metabolism: A new perspective for bone disorders 109
The interplay between cannabinoid receptors and microglia in the pathophysiology of Alzheimer's disease 101
Identification of new GSK3β inhibitors through a consensus machine learning-based virtual screening 99
A Proteomic Approach Identified TFEB as a Key Player in the Protective Action of Novel CB2R Bitopic Ligand FD22a against the Deleterious Effects Induced by β-Amyloid in Glial Cells 94
Novel Orthosteric/Allosteric Ligands of Cannabinoid Receptors: An Unexpected Pharmacological Profile 93
Positive allosteric modulation of CB1 and CB2 cannabinoid receptors enhances the neuroprotective activity of a dual CB1R/CB2R orthosteric agonist 85
Variously substituted 2-oxopyridine derivatives: Extending the structure-activity relationships for allosteric modulation of the cannabinoid CB2 receptor 83
White Grape Skin Extraction, Analytical Profile, and Biological Activity: From the Laboratory to the Industrial Scale Within a Circular Economy Framework 81
Medicinal Chemistry approach, pharmacology and neuroprotective benefits of CB2R modulators in neurodegenerative diseases 81
Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor 75
Oleocanthal and oleacein contribute to the in vitro therapeutic potential of extra virgin oil-derived extracts in non-melanoma skin cancer 71
Allosteric modulation of the cannabinoid 2 receptor confers seizure resistance in mice 70
Identification of the First Synthetic Allosteric Modulator of the CB 2 Receptors and Evidence of Its Efficacy for Neuropathic Pain Relief 68
Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis 66
Cytotoxic Activity of Oleocanthal Isolated from Virgin Olive Oil on Human Melanoma Cells 64
The endocannabinoid system dual-target ligand N-cycloheptyl-1,2-dihydro-5-bromo-1-(4-fluorobenzyl)-6-methyl-2-oxo-pyridine-3-carboxamide improves disease severity in a mouse model of multiple sclerosis 63
Modification on the 1,2-dihydro-2-oxo-pyridine-3-carboxamide core to obtain multi-target modulators of endocannabinoid system 58
Polypharmacological profile of 1,2-dihydro-2-oxo-pyridine-3-carboxamides in the endocannabinoid system 58
PSNCBAM-1 analogs: Structural evolutions and allosteric properties at cannabinoid CB1 receptor 57
Synthetic bioactive olivetol-related amides: The influence of the phenolic group in cannabinoid receptor activity 46
Totale 5.708
Categoria #
all - tutte 18.611
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.611


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022381 0 0 0 0 0 0 0 95 89 80 57 60
2022/2023633 36 69 44 23 56 92 42 59 96 26 54 36
2023/2024831 35 47 52 70 140 74 109 71 44 37 68 84
2024/20251.820 56 126 39 105 113 99 91 164 95 158 164 610
2025/20262.043 319 320 446 337 289 147 185 0 0 0 0 0
Totale 5.708